+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes



Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes



Journal of Investigative Dermatology 72(4): 187-190



Corynebacterium acnes strains cross-resistant to clindamycin and erythromycin were observed following long-term selection or mutagenic treatment in the laboratory. Similar strains were found among clinical isolates from patients using clindamycin or erythromycin topically in the treatment of acne vulgaris. Clindamycin resistance was never observed in the absence of resistance to macrolides or other lincosaminides. It is suggested that this resistance may result from an alteration of the 50S ribosomal subunit.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 005787955

Download citation: RISBibTeXText

PMID: 429800


Related references

Laboratory Induction and Clinical Occurrences of Combined Clindamycin and Erythromycin Resistance in Corynebacterium acnes. Journal of Investigative Dermatology 72(4): 187-190, 1979

In vitro sensitivity of Corynebacterium acnes (Propionibacterium acnes) to meclocycline, clindamycin, erythromycin and neomycin. Giornale Italiano di Chemioterapia 26(1-2): 203-206, 1979

Induction of clindamycin resistance in erythromycin-resistant, clindamycin susceptible and methicillin-resistant clinical Staphylococcal isolates. Saudi Medical Journal 26(12): 1914-1917, 2005

Erythromycin and clindamycin resistance in Corynebacterium diphtheriae from skin lesions. Antimicrobial Agents and ChemoTherapy 16(4): 525-527, 1979

Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrobial Agents and ChemoTherapy 49(3): 1222-1224, 2005

Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. American Journal of Medicine 60(3): 419-425, 1976

Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. Journal of Clinical Microbiology 43(4): 1716-1721, 2005

In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes. Journal of Microbiology 45(5): 473-477, 2007

Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrobial Agents and ChemoTherapy 50(5): 1875-1877, 2006

Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells. Journal of Clinical Microbiology 45(12): 3954-3957, 2007

Frequent Resistance of Clinical Group B Streptococci Isolates to Clindamycin and Erythromycin. Obstetrics & Gynecology 92(2): 258-261, 1998

Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstetrics & Gynecology. 92(2): 258-261,., 1998

Corynebacterium acnes. Presence of complement fixing antibodies to corynebacterium acnes in the sera of patients with acne vulgaris. Archives of Dermatology 93(3): 364-366, 1966

Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations. Journal of Clinical Microbiology 48(6): 2275-2277, 2010

In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory. Journal of Drugs in Dermatology 11(12): 1434-1438, 2013